Business Wire

CA-VISA

30.5.2019 13:02:12 CEST | Business Wire | Press release

Share
Visa Increases Global Investment in Women’s Soccer

Heading into the FIFA Women’s World Cup France 2019™, Visa (NYSE:V) today announced an expanded commitment to women’s soccer, leveraging the brand’s sponsorship platform to inspire women athletes amidst the global gender equality and women’s empowerment movement.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190530005245/en/

“Sport presents a huge opportunity for women to pursue their dreams on and off the field,” said Lynne Biggar, chief marketing and communications officer, Visa. “Women make the vast majority of consumer purchases and start millions of small businesses a year. By making a substantial investment in women’s initiatives, including soccer, Visa is celebrating this powerful global force.”

Visa’s Newest Investments Include:

Supporting Women’s Soccer in the U.S. and Beyond

Partnership with United States Soccer Federation

Visa has entered a five-year sponsorship agreement with the world leader in women’s soccer, the U.S. Soccer Federation, to contribute to its long-standing investment in the development of women’s soccer and support the U.S. Women’s National Team through 2023. The support of U.S. Women’s Soccer complements Visa’s global investment in women’s soccer through partnerships with UEFA Women’s Football and Visa’s longstanding partnership with FIFA, including the FIFA Women’s World Cup™, FIFA U-17 Women's World Cup Uruguay 2018 and FIFA U-20 Women's World Cup France 2018.

Visa will be the presenting sponsor of the SheBelieves Cup , which was started in the run-up to the FIFA Women’s World Cup Canada 2015™, a four-team women’s international team tournament played in the United States each year. The tournament is based around U.S. Soccer’s SheBelieves initiative, focused on inspiring young girls and women to accomplish their goals and dreams. The agreement between U.S. Soccer and Visa was facilitated by Soccer United Marketing (SUM), U.S. Soccer’s partner for the past 15 years.

“We are incredibly excited Visa is partnering with us on our overall mission to become the preeminent sport in the U.S.,” said Jay Berhalter, chief commercial officer, U.S. Soccer. “With Visa joining us in our long-term investment in women’s soccer, we will continue to increase opportunities for women players, coaches and referees at all levels. Overall, we are looking forward to Visa helping us reach our mission by increasing participation, developing world class players, coaches and referees, and increasing fan engagement.”

“Soccer United Marketing is proud to facilitate this multi-year partnership between U.S. Soccer and Visa,” said Jen Cramer, senior vice president, SUM. “We are always looking to establish partnerships with iconic, forward-thinking brands who are committed to advancing the game and developing female leaders for the next generation both in athletics and business. This exciting relationship between Visa and U.S. Soccer will elevate soccer’s popularity to even higher levels in North America, especially in advance of this summer’s FIFA Women’s World Cup™.”

Amplifying Women in Soccer

Visa is launching a new U.S. marketing campaign celebrating the U.S. Women’s National Team. The centerpiece is a new ad spotlighting stars Mallory Pugh, Becky Sauerbrunn, Rose Lavelle, Jessica McDonald, Abby Dahlkemper and Adrianna Franch as they attempt to earn a fourth star by winning the FIFA Women’s World Cup 2019™ title. The ad provides a glimpse into the players’ hard work and determination as they strive to achieve greatness on the world stage this summer. This builds upon Visa’s new global ad campaign, “One Moment Can Change the Game ,” focused on elevating women in sports.

“My teammates inspire me in so many ways every day,” said Mallory Pugh, United States Women’s National Team Forward. “I am so proud to be part of Visa’s campaign which celebrates athletes the way we are and showcases the magic moments on the field. Visa’s campaign is another incredibly empowering message for women and girls.”

Celebrating Women at the FIFA Women’s World Cup France 2019™

Player of the Match, Presented by Visa

Visa is the presenting sponsor of the Player of the Match for the FIFA Women’s World Cup 2019™, celebrating women soccer players. Soccer fans worldwide will have the opportunity to vote on FIFA.com for their favorite player for each of the 52 matches during the tournament. Players can be selected for their outstanding performance – amazing play, display of sportsmanship, or some other moment on the field.

The Player of the Match, Presented by Visa, trophy is designed to celebrate and create an opportunity for fans to have a voice and contribute to the growing recognition of the women in soccer across the world.

Team Visa Expansion

Visa’s roster of Team Visa athletes is expanding, as 18 new women’s soccer players from 16 countries will join Team Visa. They include: Ellie Carpenter (Australia), Christine Sinclair (Canada), Nadia Nadim (Denmark), Lucy Bronze (England), Fran Kirby (England), Nikita Parris (England), Eugenie Le Sommer (France), Dzsenifer Marozsán (Germany), Laura Giuliani (Italy), Shanice vd Sanden (Netherlands), Caroline Graham Hansen (Norway), Ewa Pajor (Poland), Kim Little (Scotland), Ramona Bachmann (Switzerland), Alexia Putellas (Spain), Kosovare Asllani (Sweden), Didem Karagenç (Turkey) and Megan Rapinoe (United States).

Since the beginning of the Team Visa program in 2000, on average fifty four percent of Team Visa have been women, including the newly announced 18 women soccer players from around the world. The program has supported more than 400 athletes and aims to provide athletes with the resources needed to achieve their goals on and off the field.

Visa Everywhere Initiative: Women’s Global Edition

On the opening day of the tournament on June 7, Visa will host the finals event for its first global competition focused on celebrating women entrepreneurs who are making strides in Fintech and Social Impact around the world. Twelve finalists from six regions will pitch their solutions for a chance to win the grand prize of $100,000 per challenge.

Uplifting Women from the Field to the Boardroom

Visa’s support for women goes beyond the playing field. Ninety four percent of women in the C-suite have played a sport at some time in their lives.1 Given the correlation between success in sport and business, Visa is a catalyst for supporting and championing women in all facets of life. Visa’s investment in women’s soccer globally builds on Visa’s initiatives that support women entrepreneurs and small business owners. Others include:

  • She’s Next, Empowered by Visa , a global program championing women in their efforts to fund, run and grow their small businesses.
  • Money is Changing , Visa’s multimillion-dollar campaign in the U.S., which builds on its millennial women focus and highlights practical steps women have taken to change the game and challenge existing taboos when it comes to money.

“As a leading sponsor of women’s soccer and advocate for female empowerment, Visa is dedicated to accelerating the growing support of the game, on and off the field,” continued Lynne Biggar, chief marketing and communications officer, Visa. “From championing professional players and celebrating their stories, to tapping into the strength of the Visa brand and elevating the game’s visibility across the world, Visa’s commitment to women’s soccer is here to stay.”

1 EY and espnW “Where Will You Find Your Next Leader?” study

About Visa Inc.

Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device, for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visavisa.com/blog  and @VisaNews .

Contact:

Visa Inc. Sheerin Salimi shesalim@visa.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye